Assignee
JIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO LTD
CN·7 granted patents·2 pending applications·3 citations·filing 2013–2022
Top patents by PatentIndex Score
9 records- 0175US11643405B2Compound for treatment or prevention of liver diseasesJIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO LTD·Filed 2019·Granted May 9, 2023·1 cites·8 claims
- 0272US10875865B2URAT1 inhibitor and use thereofJIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO LTD·Filed 2017·Granted Dec 29, 2020·1 cites·3 claims
- 0372US10399971B2Compound for treating or preventing hyperuricemia or goutJIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO LTD·Filed 2016·Granted Sep 3, 2019·1 cites·9 claims
- 0454US2025129012A1Anti-inflammatory and analgesic compounds and use thereofJIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0554US2024262808A1Xanthine oxidase inhibitorJIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0653USRE50083EURAT1 inhibitor and use thereofJIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO LTD·Filed 2017·Granted Aug 20, 2024·0 cites·20 claims
- 0747US11597725B2URAT1 inhibitor for promoting uric acid excretionJIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO LTD·Filed 2018·Granted Mar 7, 2023·0 cites·10 claims
- 0841US9802907B22-aryl selenazole compound and pharmaceutical composition thereofJIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO LTD·Filed 2013·Granted Oct 31, 2017·0 cites·21 claims
- 0933US10005744B2Compounds for the treatment or prevention of breast cancerJIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO LTD·Filed 2016·Granted Jun 26, 2018·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when JIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →